Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy

AIMS: Neoadjuvant chemotherapy followed by surgery is the standard of care for patients with gastro-oesophageal adenocarcinoma. Previously, we validated the utility of the tumour regression grade (TRG) as a histopathological marker of tumour downstaging in patients receiving platinum-based neoadjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Fareed, K R, Al-Attar, A, Soomro, I N, Kaye, P V, Patel, J, Lobo, D N, Parsons, S L, Madhusudan, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883154/
https://www.ncbi.nlm.nih.gov/pubmed/20461087
http://dx.doi.org/10.1038/sj.bjc.6605686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883154/
https://www.ncbi.nlm.nih.gov/pubmed/20461087
http://dx.doi.org/10.1038/sj.bjc.6605686

Ejemplares similares